Position in RPRX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$120,830
+$17,455 QoQ
Shares Held
2,155
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#513
of 641 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $866,211 across 15 Biotechnology names. RPRX ranks #4 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
588 | $167,562 | |
| 2 | ARGX |
Argenx SE
|
145 | $134,526 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
2,422 | $132,095 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
2,155 | $120,830 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
191 | $119,096 | |
| 6 | INCY |
Incyte Corp
|
1,000 | $113,360 | |
| 7 | GMAB |
Genmab A/S
|
1,333 | $36,617 | |
| 8 | MRNA |
Moderna, Inc.
|
230 | $16,106 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,830 | 2,155 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $103,375 | 2,155 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $83,269 | 2,155 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $76,028 | 2,155 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $77,644 | 2,155 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $67,085 | 2,155 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $54,974 | 2,155 | Shares | Sole | 2025-02-03 | |
| No filing history on record for this holder in this stock. | ||||||